Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Gels × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 12 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Parapsoriasis 1 Non-Melanoma Skin Cancers 1 Non-Melanoma Skin Cancer (NMSC) 1 Keratosis, Seborrheic 1 Dermatitis, Contact 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1

Interventions

HhAntag691 25 Imiquimod 12 Biopsy 12 sonidegib 11 Aminolevulinic Acid 9 cemiplimab 8 Photochemotherapy 8 methyl 5-aminolevulinate 7 Nivolumab 7 Mohs Surgery 7 1-phenyl-3,3-dimethyltriazene 7 Tomography, Optical Coherence 6 Surgical Procedures, Operative 6 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Specimen Handling 4 Microscopy, Confocal 4 Ipilimumab 4 Curettage 4 Standard of Care 3 Niacinamide 3 Magnetic Resonance Spectroscopy 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡